The Neurobiology of Addiction. Angela Haliburda, DO

Similar documents
Council on Chemical Abuse Annual Conference November 2, The Science of Addiction: Rewiring the Brain

Neurobiology of Addiction

Neurobiology of Addiction JeanAnne Johnson Talbert, DHA, APRN BC, FNP, CARN AP

MOLECULAR BIOLOGY OF DRUG ADDICTION. Sylvane Desrivières, SGDP Centre

CHAPTER 2. THE NEUROBIOLOGY OF SUBSTANCE USE, MISUSE, AND ADDICTION

590,000 deaths can be attributed to an addictive substance in some way

BRAIN MECHANISMS OF REWARD AND ADDICTION

Ken Winters, Ph.D. Department of Psychiatry University of Minnesota Midwest Conference on Problem Gambling August 11, 2004

If you give any person a prescription of something like Valium and have them take it on

The Biology of Addiction

MANAGING PAIN IN PATIENTS WITH SUBSTANCE USE DISORDER

The Role of Smoking in Cocaine. Addiction

Possession by evil spirits? Demon rum. Lack of moral fiber? War on drugs Just say no

Understanding Addiction: Why Can t Those Affected Just Say No?

Opioid Epidemic Update

The Neurobiology of Addiction

National Institute on Drug Abuse (NIDA) Understanding Drug Abuse and Addiction: What Science Says

At a Glance. Background Information. Lesson 3 Drugs Change the Way Neurons Communicate

Drugs, addiction, and the brain

The Biological Perspective. Jørg Mørland Senior researcher, Norwegian Institute of Public Health Professor em of Medicine University of Oslo

How Addiction Affects the Brain: The Neuroscience of Compulsive Behavior

The Adolescent Developmental Stage

nucleus accumbens septi hier-259 Nucleus+Accumbens birnlex_727

Opioid Overdose Epidemic A Crises and Opportunity

Understanding Addiction

Key Concepts. Machinery of the Mind. The Growing Cycle. Six Brain Mind Functions. Machinery of the Mind 6/1/2012

General introduction. Chapter 1

The Neuroscience of Addiction: A mini-review

Understanding the Brain: What Drugs Can Tell Us

What are Substance Use Disorders?

Module 1 CREATE. Diagram. Getting the hardware sorted: How your brain works. Outside appearance of the human brain

Understanding Addiction and Its Impact on the Brain. SDSMA Webinar Matthew Stanley, DO

The Contribution of Neuroscience to Understanding Human Behaviour

Understanding Alcohol And Other Drugs Of Abuse

Brain Imaging studies in substance abuse. Jody Tanabe, MD University of Colorado Denver

Transcriptional and Epigenetic Mechanisms of Addiction

The Human Animal Drugs of Plant Origin

The Neurobiology of Drug Addiction

The Brain, Behavior and Addiction National Family Dialogue January 27, 2010 Presenter: Flo Hilliard, MSH University of Wisconsin-Madison

Understanding Addiction and Dugs Of Abuse

The Neurochemistry of Relapse & Recovery Worksheets to accompany the video by CNS Productions, Inc.

Part IV: Slipping Up: Neuroscience Basis of Relapse & Recovery July 31, am 12:30 pm with Break 10-10:15am

11/7/2016. Possession by evil spirits? Demon rum. Lack of moral fiber? War on drugs Just say no

Substance Abuse and Addictions Substance abuse: a pattern of substance use that produces clinically significant impairment or distress.

HIV and alcohol use: why is risk reduction in alcohol use important in HIV care?

ECHO Presentation Addiction & Brain Function

processes in the central nervous system (CNS), affecting many of the during the course of ethanol treatment. Ethanol stimulates the release of

Physical and Physiological Aspects of Drug Use and Abuse

Brain Health and Opioid Abuse

Effects of Drugs on the Brain and Behavior in Adolescents

Addiction in the Brain - Latest Research. Gary M. Henschen, MD, LFAPA Chief Behavioral Health Officer Magellan Healthcare, Inc.

Psychoactive drugs Drugs which affect mental processes. Legal but restricted (by prescription only)

LESSON 3.4 WORKBOOK. Can you become addicted to food?

18. Mind and Addiction

Eighth Edition. Part I: Current Science of Addiction, Relapse & Recovery: Dispelling The Stigmas

Drugs, Brain and Behavior

Chapter 5: Learning and Behavior Learning How Learning is Studied Ivan Pavlov Edward Thorndike eliciting stimulus emitted

Psychology in Your Life

Listen & Hear 4Lo

Modeling Neurotransmission and Drugs. CHM 108 Lab. Spring Dr. Angela King

Cell body, axon, dendrite, synapse

Neurobiology of Addiction. Jon E. Grant, JD, MD, MPH Professor University of Chicago

by popular demand: Addiction II

FLAME TEEN HANDOUT Week 9 - Addiction

BASIC VOLUME. Elements of Drug Dependence Treatment

Defining & diagnosing addiction

Basal Ganglia General Info

Understanding the Impact of Cigarette Smoking Using Brain Imaging

Neurobiology of addiction and why it is important

The Nervous System. Anatomy of a Neuron

Classes of Neurotransmitters. Neurotransmitters

ADHD & Addictions -What We Know

Brain Stimulation in the Study and Treatment of Addiction. From Animal Models to Humans

The Addicted Brain. Abstract. 1 Introduction. Eric J. Nestler and Robert C. Malenka. March 2004

Neuroscience, Zen, and the Art of Coaching for Habitual Excellence. Process Quest, LLC Marsha Pomeroy-Huff 17 September 2013

Tobacco Dependence Treatment From Neurobiology through Public Policy

Brain Reward Pathway and Addiction

Psychoactive Drugs. Psychoactive drug: A chemical substance that alters perceptions and mood.

America is a drugged society

Synaptic plasticity and addiction

Action Potentials and Synaptic Transmission. BIO 219 Napa Valley College Dr. Adam Ross

DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.

Long term pharmacotherapy for Alcohol Dependence: Anti Craving agents

Management of Tobacco Dependence. Dr. Lokesh Kumar Singh Associate Professor Department of Psychiatry AIIMS, Raipur

Addiction. Counselling. Short Course STUDY GUIDE

PSYCHOLOGICAL DISORDERS CHAPTER 13 MEYERS AND DEWALL

Physiology Unit 2 CONSCIOUSNESS, THE BRAIN AND BEHAVIOR

C81ADD Psychology of Addiction. Alcohol. Ethyl alcohol (ethanol) School of Psychology. Tobias Bast.

Cogs 107b Systems Neuroscience lec9_ neuromodulators and drugs of abuse principle of the week: functional anatomy

THE MEDICAL MODEL: ADDICTION IS A BRAIN DISEASE. Judith Martin, MD Medical Director of Substance Use Services San Francisco Dept.

The Neurobiology of Learning and Memory

Prefrontal dysfunction in drug addiction: Cause or consequence? Christa Nijnens

THE SCIENCE OF RECOVERY: AN ADVANCED SEMINAR. CARDWELL C. NUCKOLS, PhD

Excited Delirium and Sudden Death. William A. Cox, M.D., FCAP Forensic Pathologist/Neuropathologist. December 14, 2018

Psychotropic Drugs Critical Thinking - KEY

The Neurobiology of Street Drugs. Joe Gilboy PA-C Hoag Hospital Emergency Department Irvine, CA. Neuroplasticity. Question #1

BIOLOGY 12 TRANSMISSION OF IMPULSES ACROSS SYNAPSES

Module 22- Understanding Consciousness & Hypnosis

This article reviews scientific advances in the prevention and

Psychology 210. Chemical Messengers. Types of NTs. Properties of Neurotransmitters. Cholinergic Neurons. Small molecule NTs.

Transcription:

The Neurobiology of Addiction Angela Haliburda, DO

Currently, 8-10% of those age 12+ years, or 20 million to 22 million Americans are addicted to alcohol or other drugs. Drug overdoses are now the leading cause of injury-related death in the USA - worse than guns, car crashes or suicides. In the heroin-addicted America of 2016: Another 350 people start on heroin every day Another 4,105 visit emergency rooms Another 79 people die (CDC estimates) Heroin abuse has quadrupled in the past decade and most addicts are introduced to heroin through prescription pain pills. Doctors write more than 200 million opiate prescriptions each year.

4-carbomethoxyfentanyl = Carfentanyl

Children dream of becoming many things.

No child dreams of becoming an addict.

Who would want to do this to themselves? Nobody in their right mind. Maybe they are not in their right mind.

Addiction. Is it a Disease?

The Disease Model of Addiction *Addiction is a primary, chronic disease of the brain. *It is a disease because drugs modify brain chemistry and the structure of cells and circuits involved with reward, motivation, learning and memory. *In the addictive brain, drugs hijack normal learning pathways and activate reward circuits in response to drug-associated cues, which leads to cravings and compulsive drug seeking behavior, despite harmful consequences. *The clinical significance of these brain changes is that addiction, once established, becomes a chronic illness with relapses and remissions.

The idea that addicts voluntarily chose to use drugs of addiction doesn t make the addiction any less of a disease. There are many chronic diseases, such as COPD, HTN, CAD, DM, that originate with voluntary lifestyle choices. There s a genetic component to diseases (CF, SCA, Huntington s, BRCA1). Twin and adoption studies show a genetic component to alcoholism. Knowing that drugs of abuse can lead to addiction doesn t deter many from experimenting with drugs because the majority of people who use addictive drugs don t become addicted. While the initial choice to use drugs of abuse may have been voluntary, changes in the brain from use of these drugs make it difficult for the addict to voluntarily stop using.

The Disease Model of Addiction Unhealthy biological structures are rightly termed diseased, regardless of the organ involved From the laboratories of Drs. N. Volkow and H.Schlbert

All known addictive drugs activate reward regions in the brain by causing sharp increases in the release of dopamine. At the receptor level, these increases elicit a reward signal that triggers associated learning or conditioning. In this Pavlovian-type learning, repeated rewards become associated with the environmental stimuli that precede them. With repeated exposure to the same reward, dopamine cells stop firing in response to the reward itself and instead fire in an anticipatory response to the conditioned stimuli ( cues ) that predict the delivery of the reward. This process involves the same molecular mechanisms that strengthen synaptic connections during learning and memory formation

Addiction involves the reward pathways of the brain

In the Disease Model of Addiction, there are Stages of Addiction 1.) Binge and Intoxication. 2.) Withdrawal and Negative Affect 3.) Preoccupation and Anticipation (cravings) Each stage is associated with the activation of specific neurobiological circuits and resultant clinical and behavioral characteristics

Stage 1. Intoxication You like the euphoric feeling, so you use it again. The more you use it, the more the brain changes and this creates negative effects when not using it, which leads to Stage 2. Withdrawal You feel distressed and to get rid of this distress, you think of using the drug again, which leads to Stage 3. Preoccupation and Cravings Cues initiate cravings for the drug and this leads to repeated use and intoxication

What causes these brain changes? All known addictive drugs increase the release of Dopamine

Nicotine binds directly to acetylcholine receptors on dopamine cells and increases the firing frequency of dopamine neurons.

Alcohol increases dopamine cell firing and dopamine release in axon terminal fields.

Cocaine inhibits the binding of dopamine to the transporter and increases extracellular dopamine.

All known addictive drugs increase the release of Dopamine

The release of dopamine triggers Neuroplasticity

The Concept of Neuroplasticity Neuroplasticity = the potential of the brain to reorganize itself by creating new neural connections. Through axonal sprouting axons grow new nerve endings and form new neural pathways. These new neural pathways allow for systematic changes in the synaptic signaling, or communication, between neurons in various reward regions of the brain. These neuroplastic changes are fundamental to learning and memory and strengthen drug-associated behaviors.

Experience-dependent learning, which occurs in repeated episodes of drug use, invokes both long term potentiation, which increases the transmission of signals between neurons and long-term depression, in which signals are decreased. Changes in long-term potentiation and depression are in turn associated with larger or smaller synapses, respectively, and differences in the shapes of the dendritic spines in the receptive site of the receiving neuron. Synaptic strength is controlled by the insertion or removal of receptors that are stimulated by the excitatory NT glutamate.

Neuroplastic changes triggered by drugs occur in the: Nucleus accumbens (the crucial brain reward region) Dorsal striatum (associated with the encoding of habits and routines), Amygdala (associated with emotions, stress and desires ) Hippocampus (region involved in memory) Prefrontal cortex (an area involved with self-regulation and the assignment of relative value). All these regions of the brain participate in the various stages of addiction, including conditioning and craving. These regions also regulate the firing of dopamine cells and the release of dopamine.

Cocaine causes transcription-dependent neuroplasticity in the reward pathways. It alters the dynamics of numerous neurotransmitter systems in the mesocorticolimbic region of the brain: the ventral tegmental area (VTA), nucleus accumbens (NAc), and prefrontal cortex (PFC). These areas are critical for reward, reinforcement, and higher cognitive functions. Cocaine indirectly enhances the levels of dopamine at the interface between VTA cells and NAc cells by binding to and blocking DAT. The activation of D1 and D2-type DA receptors stimulates intracellular signaling cascades that direct transcription factor binding to DNA. HATs and HDACs have opposing actions to push the equilibrium one way or the other. Histone acetylation (by HATs) generally allows for TF binding and gene expression while histone deacetylation (by HDACs) represses transcription.

Adapted from Nestler, McQuown and Wood (2010).

Glutamate is released by cortical and limbic terminals when exposed to drugs or drug cues. Glutamate acts largely through α-amino-3-hydroxy-5-methyl-4- isoxazolepropionic acid [AMPA] and N-methyl-d-aspartate [NMDA] receptors. Glutamate helps to up-regulate AMPA receptors. The up-regulation of AMPA receptors increases the responsiveness of the nucleus accumbens to glutamate. Specifically, the insertion of a subunit of the AMPA receptor that is highly permeable to calcium, the glutamate receptor 2 (GluR2), enhances the efficiency of transmission. This has been shown to contribute to long-term potentiation in addiction.

Withdrawal and Negative Affect Repeated exposure to dopamine leads to changes in the circuitry of the amygdala, which increases a person s reactivity to stress and results in the emergence of negative emotions. This anti-reward system is fueled by the neurotransmitters involved in the stress response, such as corticotropin-releasing factor and dynorphin. In the addicted brain, the anti-reward system becomes overactive, giving rise to a highly dysphoric phase that ensues when the direct effects of the drug wear off. To counter the direct and conditioned pull toward the rewards of drug use, there is a correspondingly intense motivational push to escape the discomfort associated with the aftereffects of use. The addict transitions from taking drugs simply to get high and feel pleasure, to taking them to obtain relief from dysphoria

Neuroplasticity effects: Changes in the circuitry of the Amygdala increase sympathetic activation Heroin Noradrenaline When heroin use stops, unopposed sympathetic noradrenaline predominates and causes withdrawal symptoms: increased HR, RR, BP, anxiety, diarrhea

Preoccupation and Anticipation: In addition to changes in the basal forebrain that lead to stress and cravings, changes also occur in the prefrontal cortex of the brain. This is where "executive processes" such as the capacity for selfregulation, decision making, flexibility in the selection and initiation of action, attributing relative value and the monitoring of error. Changes in the emotional circuits of prefrontal regions are disrupted by neuroplastic changes in glutamate signaling, which weakens a user s ability to resist strong urges and to follow through on decisions to stop taking the drug. This explains why addicts may sincerely desire to stop using a drug, but are simultaneously impulsive and unable to follow through on their resolve.

Dopamine cells stop firing with repeated exposure to natural rewards (food, sex) as satiety develops, but addictive drugs circumvent natural satiation and continue to release dopamine. This explains why compulsive behaviors predominate with drug use and not with natural rewards. Compulsive behaviors are also related to environmental cues and triggers. The environmental stimuli that are repeatedly paired with drug use (the place, persons and mental state involved with the process of drug use) can elicit conditioned surges of dopamine release that trigger craving for the drug, motivate drug-seeking behaviors, and lead to heavy binge use of the drug. These conditioned responses become deeply ingrained and can continue to trigger strong cravings for a drug long after use has stopped.

It was previously thought that drug addicts become more sensitive to the rewarding effects of drugs, resulting in higher levels of dopamine in the reward circuits of their brains, but, on the contrary, continued drug use triggers attenuated increases in dopamine levels in an addict. This decreased release of dopamine renders the addicts s brain reward system much less sensitive to stimulation by both drug-related and non drug-related rewards. Addicts no longer experience the same degree of euphoria from a drug as they did when they first started using it. They also become less motivated by everyday stimuli that was previously motivating and rewarding. Because their systems for reward and motivation become reoriented through conditioning to focus on the release of dopamine produced by the drug and its cues. The landscape of the addict becomes restricted to the cues and triggers of drug use. These changes become deeply ingrained and cannot be immediately reversed through the simple termination of drug use (e.g., detoxification).

Persons with addiction frequently continue to take the drug even when it no longer seems pleasurable. Many take the drug to escape the distress they feel when they are not intoxicated. Although the short-acting effects of increased dopamine levels triggered by drug administration temporarily relieve this distress, the result of repeated binge use is to deepen the dysphoria during withdrawal. This produces a vicious cycle.

You get high & feel better Feedback loop The effect wears off, you crash You feel terrible and want to feel good again You seek more drug

Just after I'd shoot up, I'd get an amazing rush. I'd be on top of the world. Once the high really set in, my mind would get slow and fuzzy. It'd feel like I was sinking into the floor. I'd forget if I was asleep or awake, and time just passed me by. I got hooked quick. After a while, I needed heroin just to get by. Too long without a fix, and I can't even describe it. It's like I was dying in every awful way you could think of, all at once. Pain in all my bones, throwing up, chills, and I couldn't sleep for days. The second time I got busted, the judge decided to put me in a drug treatment program. I was so angry. I didn't want to stop using. I just wanted another fix. When I got out of jail, I decided I'd control my drug use better, and stay out of trouble. But there's no such thing as "control" when it comes to addiction. You just want more and more, and will do all kinds of crazy things to get high again.

Only a minority of people who use drugs ultimately become addicted just as not everyone is equally at risk for the development of other chronic diseases. Susceptibility differs because people differ in their vulnerability to various genetic, environmental, and developmental factors and it is these factors that contribute to the determination of a person s unique susceptibility to using drugs initially, sustaining drug use, and undergoing the progressive changes in the brain that characterize addiction. Although long-term exposure to drugs is a necessary condition for the development of addiction, it is by no means sufficient. In those persons where drug use progresses to addiction, the neurobiologic changes are distinct and profound. It is estimated that the most severe phenotypic characteristics of addiction will develop in approximately 10% of persons exposed to addictive drugs. The other 90% gives us an estimate of the magnitude of the problem.

Disease of the Brain?? How do we treat it?